Post-Treatment-Free Dual-Interface Passivation via Facile 1D/3D Perovskite Heterojunction Construction.

For achieving high-efficiency perovskite solar cells, it is almost always necessary to substantially passivate defects and protect the perovskite structure at its interfaces with charge transport layers. Such a modification generally involves the post-treatment of the deposited perovskite film by spin coating, which cannot meet the technical demands of scaling up the production of perovskite photovoltaics. In this work, we demonstrate one-step construction of buried and capped double 1D/3D heterojunctions without the need for any post-treatment, which is achieved through facile tetraethylammonium trifluoroacetate (TEATFA) prefunctionalization on the SnO2 substrate. The functional TEATFA salt is first deposited onto the SnO2 substrate and reacts on this buried interface. Once the FAPbI3 perovskite precursor solution is dripped, a portion of the TEA+ cations spontaneously diffuse to the top surface over film crystallization. The TEATFA-based water-resistant 1D/3D TEAPbI3/FAPbI3 heterojunctions at both the buried and capped interfaces lead to much better photovoltaic performance and higher operational stability. Since this approach saves the need for any postsynthesis passivation, its feasibility for the fabrication of large-area perovskite photovoltaics is also showcased. Compared to ∼15% for a pristine 5 cm × 5 cm FAPbI3 mini-module without postsynthesis passivation, over 20% efficiency is achieved following the proposed route, demonstrating its great potential for larger-scale fabrication with fewer processing steps.

Myth behind Metastable and Stable n-Hexylammonium Bromide-Based Low-Dimensional Perovskites.

In perovskite solar cells, passivating the surface or interface that contains a high concentration of defects, specifically deep-level defects, is one of the most important topics to substantially enhance the power conversion efficiency and stability of the devices. Long-chain alkylammonium bromides have been widely and commonly adapted for passivation treatment. However, the mechanism behind is still not well explored as the formation route and the exact structure of these alkylammonium bromide-based low-dimensional perovskites are unclear. Herein, we investigate the physical and chemical properties of an n-hexylammonium bromide (HABr)-based low-dimensional perovskite including both thin films and single crystals. First of all, the HA2PbBr4 perovskite film and aged single crystal demonstrate different X-ray diffraction patterns from those of the fresh as-prepared single crystal. We found that the fresh HA2PbBr4 single crystal exhibits a metastable phase as its structure changes with aging due to the relaxation of crystal lattice strains, whereas the HA2PbBr4 perovskite film is pretty stable as the aged single crystal. Upon reacting with FAPbI3, HABr can be intercalated into the FAPbI3 lattice to form a mixed-cation perovskite of HAFAPbI3Br, which is in a dynamic equilibrium of decomposition and formation. In contrast, the reaction of HABr with excess PbI2 forms a stable HA2PbI2Br2 perovskite. Based on such findings, we rationally develop a HA2PbI2Br2-passivated FACs-based perovskite by reacting HABr with excess PbI2, the photovoltaics based on which are more stable and efficient than those passivated by the HAFAPbI3Br perovskite. Our discovery paves way for a more in-depth study of bromide-containing low-dimensional perovskites and their optoelectronic applications.

Identification of Long Noncoding RNAs That Exert Transcriptional Regulation by Forming RNA-DNA Triplexes in Prostate Cancer.

Long noncoding RNAs (lncRNAs) are involved in transcriptional regulation, and their deregulation is associated with the development of various human cancers, including prostate cancer (PCa). However, their underlying mechanisms remain unclear. In this study, lncRNAs that interact with DNA and regulate mRNA transcription in PCa were screened and identified to promote PCa development. First, 4195 protein-coding genes (PCGs, mRNAs) were obtained from the The Cancer Genome Atlas (TCGA) database, in which 1148 lncRNAs were differentially expressed in PCa. Then, 44,270 pairs of co-expression relationships were calculated between 612 lncRNAs and 2742 mRNAs, of which 42,596 (96%) were positively correlated. Among the 612 lncRNAs, 392 had the potential to interact with the promoter region to form DNA:DNA:RNA triplexes, from which lncRNA AD000684.2(AC002128.1) was selected for further validation. AC002128.1 was highly expressed in PCa. Furthermore, AD000684.2 positively regulated the expression of the correlated genes. In addition, AD000684.2 formed RNA-DNA triplexes with the promoter region of the regulated genes. Functional assays also demonstrated that lncRNA AD000684.2 promotes cell proliferation and motility, as well as inhibits apoptosis, in PCa cell lines. The results suggest that AD000684.2 could positively regulate the transcription of target genes via triplex structures and serve as a candidate prognostic biomarker and target for new therapies in human PCa.

Steroidal saponins from the rhizome of Paris polyphylla and their cytotoxic activities.

Two new furostanol saponins and one new spirostanol saponin were isolated from the rhizome of Paris polyphylla Smith var. yunnanensis, together with 18 known steroidal saponins. The structures of the new steroidal saponins were elucidated as 26-O-beta-D-glucopyranosyl-(25R)-5-ene-furost-3 beta, 17 alpha, 22 alpha, 26-tetrol-3-O-alpha-L-arabinofuranosyl-(1-->4)-[alpha-L-rhamnopyranosyl-(1-->2)]-beta-D-glucopyranoside (2, parisyunnanoside A), 26-O-beta-D-glucopyranosyl-(25R)-5, 20 (22)-diene-furost-3 beta, 26-diol-3-O-alpha-L-arabinofuranosyl-(1-->4)-[alpha-L-rhamnopyranosyl-(1-->2)]-beta-D-glucopyranoside (7, parisyunnanoside B), and (25R)-spirost-5-ene-3 beta, 12 alpha-diol-3-O-alpha-L-rhamnopyranosyl-(1-->4)-alpha-L-rhamnopyranosyl-(1-->4)-[alpha-L-rhamnopyranosyl-(1-->2)]-beta-D-glucopyranoside (13, parisyunnanoside C) by MS and 1 D and 2 D NMR analysis. The isolated compounds were evaluated for their cytotoxicity against HL-60 human promyelocytic leukemia cells. Our results showed that the spirostanol framework of the aglycone and the terminal alpha-L-rhamnopyranosyl with 1-->2 linkage to the sugar chain of saponins at C-3 are essential for their high cytotoxicity, whereas the hydroxy group substitution at C-12 or C-17 of the aglycone causes a reduction in their activity.